Jack Nathan Medical (TSXV:JNH) EBIT: C$-7.76 Mil (TTM As of Oct. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Jack Nathan Medical EBIT?

Jack Nathan Medical TSXV:JNH EBIT is C$-7.76 Mil as of Oct. 2023.

Jack Nathan Medical's earnings before interest and taxes (EBIT) for the three months ended in Oct. 2023 was C$-1.59 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Oct. 2023 was C$-7.76 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Jack Nathan Medical's annualized ROC % for the quarter that ended in Oct. 2023 was -53.14%. Jack Nathan Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Oct. 2023 was -178.49%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Jack Nathan Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Oct. 2023 was -107.87%.

Jack Nathan Medical  (TSXV:JNH) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Jack Nathan Medical's annualized ROC % for the quarter that ended in Oct. 2023 is calculated as:

ROC % (Q: Oct. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jul. 2023 ) + Invested Capital (Q: Oct. 2023 ))/ count )
=-3.716 * ( 1 - 0% )/( (6.744 + 7.243)/ 2 )
=-3.716/6.9935
=-53.14 %

where

Invested Capital(Q: Jul. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=12.573 - 2.741 - ( 7.242 - max(0, 5.108 - 8.196+7.242))
=6.744

Invested Capital(Q: Oct. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=11.906 - 4.052 - ( 5.288 - max(0, 6.338 - 6.949+5.288))
=7.243

Note: The Operating Income data used here is four times the quarterly (Oct. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Jack Nathan Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Oct. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Oct. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jul. 2023  Q: Oct. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-6.356/( ( (3.269 + max(-1.909, 0)) + (3.853 + max(-2.648, 0)) )/ 2 )
=-6.356/( ( 3.269 + 3.853 )/ 2 )
=-6.356/3.561
=-178.49 %

where Working Capital is:

Working Capital(Q: Jul. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.784 + 0 + 0.048) - (2.741 + 0 + -8.8817841970013E-16)
=-1.909

Working Capital(Q: Oct. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.19 + 0 + 0.214) - (4.052 + 0 + 8.8817841970013E-16)
=-2.648

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Oct. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Jack Nathan Medical's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Oct. 2023 )
=-7.758/7.192
=-107.87 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jack Nathan Medical EBIT Related Terms

Jack Nathan Medical EBIT Historical Data

* Premium members only.

The historical data trend for Jack Nathan Medical's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jack Nathan Medical EBIT Chart

Jack Nathan Medical Annual Data
Trend Dec18 Dec19 Jan20 Jan21 Jan22 Jan23
EBIT
Get a 7-Day Free Trial -0.14 0.00 -10.26 -8.05 -6.58

Jack Nathan Medical Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.78 -3.24 -1.48 -1.45 -1.59

TSXV:JNH vs HCA, UHS, CHE: EBIT Comparison

For the Medical Care Facilities subindustry, Jack Nathan Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jack Nathan Medical EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jack Nathan Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Jack Nathan Medical's EV-to-EBIT falls into.


Jack Nathan Medical EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Oct. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-7.76 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of C$-7.76 Mil mean?
Jack Nathan Medical (TSXV:JNH) has a EBIT of C$-7.76 Mil as of Oct. 2023. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Jack Nathan Medical.
Is Jack Nathan Medical's EBIT too high?
Jack Nathan Medical's current EBIT is C$-7.76 Mil.
How does Jack Nathan Medical's EBIT compare to HCA and UHS?
Jack Nathan Medical's EBIT of C$-7.76 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Providers & Services company?
A good EBIT depends on the Healthcare Providers & Services industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Jack Nathan Medical. Jack Nathan Medical's current EBIT is C$-7.76 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jack Nathan Medical stock overvalued right now?
Jack Nathan Medical (TSXV:JNH) has a current EBIT of C$-7.76 Mil. The current EBIT is C$-7.76 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Jack Nathan Medical (TSXV:JNH), the current EBIT is C$-7.76 Mil as of Oct. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Jack Nathan Medical Business Description

Address 6 - 6150 Highway 7, Suite 491, Jack Nathan Health, Woodbridge, ON, CAN, L4H 0R6
Jack Nathan Medical Corp is a provider of primary care medical clinics located in Walmart Supercentres under the Jack Nathan Health brand. The company designs, builds and sets barrier-free medical clinics for physicians in high-density centers, providing patients with an opportunity to receive immediate access to quality care in modern facilities.